Open field testing performed on day 28 indicated that treatment with 1 μg/g C-MANF caused a nonsignificant trend toward increased ambulation ( Figures S1 A–S1D).
← all excerpts
Modulation of the unfolded protein response with a C-terminal fragment of MANF facilitates recovery in models of multiple sclerosis.
1
—
—